- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
ATL shifts cardiology management
Ultrasound vendor ATL promoted several sales officers in its cardiology organization this month. The company expanded the duties of Bob Dockendorff, vice president of North American sales, to include additional responsibility for its U.S. cardiology
Ultrasound vendor ATL promoted several sales officers in its cardiology organization this month. The company expanded the duties of Bob Dockendorff, vice president of North American sales, to include additional responsibility for its U.S. cardiology sales unit. William Doherty, formerly vice president of Bothell, WA-based ATLs U.S. cardiology sales, has been promoted to the post of vice president of the companys global cardiology business development. Doherty will work with the companys global distribution and marketing groups. Finally, ATL promoted Allan Criss to the position of vice president, U.S. cardiology sales, reporting to Dockendorff. ATL expects the moves to unify its North American sales distribution structure and increase its focus on its global cardiology business.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
